Low-Dose Chemoreduction for Infants Diagnosed with Retinoblastoma before 6 Months of Age.
about
Risk of metastasis and orbital recurrence in advanced retinoblastoma eyes treated with systemic chemoreduction versus primary enucleation.Long-term outcomes of Group D retinoblastoma eyes during the intravitreal melphalan era.Patterns of subretinal fluid resolution in Group D eyes treated with chemoreduction: Experience from the Children's Hospital Los Angeles/University of Southern California.Potential of Aqueous Humor as a Surrogate Tumor Biopsy for Retinoblastoma.Optic Nerve Obscuration in Retinoblastoma: A Risk Factor for Optic Nerve Invasion?
P2860
Low-Dose Chemoreduction for Infants Diagnosed with Retinoblastoma before 6 Months of Age.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Low-Dose Chemoreduction for Infants Diagnosed with Retinoblastoma before 6 Months of Age.
@en
type
label
Low-Dose Chemoreduction for Infants Diagnosed with Retinoblastoma before 6 Months of Age.
@en
prefLabel
Low-Dose Chemoreduction for Infants Diagnosed with Retinoblastoma before 6 Months of Age.
@en
P2093
P2860
P356
P1476
Low-Dose Chemoreduction for Infants Diagnosed with Retinoblastoma before 6 Months of Age.
@en
P2093
A Linn Murphree
Jesse L Berry
Jonathan W Kim
Rima Jubran
Thomas C Lee
P2860
P304
P356
10.1159/000370215
P577
2015-01-16T00:00:00Z